3/14
01:32 am
fhtx
Low
Report
3/12
07:01 pm
fhtx
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/12
11:22 am
fhtx
Foghorn Therapeutics (FHTX) had its "outperform" rating reaffirmed by Wedbush. They now have a $10.00 price target on the stock.
Low
Report
Foghorn Therapeutics (FHTX) had its "outperform" rating reaffirmed by Wedbush. They now have a $10.00 price target on the stock.
3/11
04:44 pm
fhtx
Foghorn Therapeutics GAAP EPS of -$1.18 misses by $0.08, revenue of $30.91M misses by $0.31M [Seeking Alpha]
High
Report
Foghorn Therapeutics GAAP EPS of -$1.18 misses by $0.08, revenue of $30.91M misses by $0.31M [Seeking Alpha]
3/11
04:22 pm
fhtx
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook [Yahoo! Finance]
High
Report
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook [Yahoo! Finance]
3/11
04:09 pm
fhtx
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
High
Report
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
3/10
08:03 am
fhtx
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $13.00 price target on the stock.
2/24
07:23 am
fhtx
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
2/24
07:00 am
fhtx
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
Low
Report
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
2/23
07:00 am
fhtx
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
Low
Report
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
2/17
08:10 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Jefferies Financial Group Inc..
Low
Report
Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Jefferies Financial Group Inc..
2/3
07:00 am
fhtx
Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit
Low
Report
Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit
1/13
04:05 pm
fhtx
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
Medium
Report
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
1/9
10:20 pm
fhtx
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
High
Report
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026